Clinical trial

Initiation of ARNi and SGLT2i in Patients With HFrEF

NCT05989503

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2023-08-04

PhasePHASE4

Study timeline

Study start (actual)2023-08-04Date precision: day

Registry last updated2025-11-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failure With Reduced Ejection Fractionunresolved

Interventions

Sacubitril-valsartanDRUG

SGLT2 inhibitorDRUG

Sponsors & collaborators

Universidade do Portolead sponsor

Unidade de Investigação e Desenvolvimento Cardiovascular (UnIC)collaborator

Rede de Investigação em Saúdecollaborator

Mapped research locations

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05989503 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.